0001235802-19-000105.txt : 20190816 0001235802-19-000105.hdr.sgml : 20190816 20190816163122 ACCESSION NUMBER: 0001235802-19-000105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190816 FILED AS OF DATE: 20190816 DATE AS OF CHANGE: 20190816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pauls Dietrich John CENTRAL INDEX KEY: 0001760123 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36291 FILM NUMBER: 191033835 MAIL ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: 2 CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-08-16 0 0001401040 DiaMedica Therapeutics Inc. DMAC 0001760123 Pauls Dietrich John 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 1 1 0 0 President and CEO Voting Common Shares, no par value per share 2019-08-16 4 P 0 1000 2.6769 A 30804 D Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan. /s/ Amy Culbert, attorney-in-fact 2019-08-16